.png)
Pfizer acquisition news took center stage today as the company confirmed it has closed its purchase of Metsera, a clinical-stage biotech pushing new treatments for obesity and cardiometabolic disease. The move marks a major step for Pfizer as it...
Sun Pharmaceutical Industries Limited (Sun Pharma), India’s leading pharmaceutical company by revenue and prescriptions, has rolled out the #SeeBeyondSugar campaign — a national initiative aimed at boosting awareness and education around diabetic
Indian pharma major Lupin announced today the U.S. launch of Risperidone extended-release injectable suspension in 25 mg, 37.5 mg and 50 mg single-dose vials, marking a significant strategic move in the long-acting injectable (LAI) market...
AstraZeneca’s Baxdrostat has achieved a major milestone in the treatment of resistant hypertension (rHTN).Phase III trials demonstrate very large and long-term improvements in blood-pressure. The drug blocks the hormone aldosterone by inhibiting...
Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., has announced new findings from the ongoing real-world IMPACT-TD Registry, which underscore the beneficial effects of AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR
Granules India announced that its subsidiary, Granules Life Sciences (GLS), based in Hyderabad, has obtained approval from the U.S. Food and Drug Administration (FDA) for a product that underwent a pre-approval inspection (PAI)
Glenmark Specialty S.A.,a subsidiary of Glenmark Pharmaceuticals Ltd. that is fully owned, announced that its innovative nasal spray for allergic rhinitis, Ryaltris Compound Nasal Spray (GSP 301 NS), has received approval from China
Marksans Pharma experienced an increase of 1.94%, reaching Rs 186.30, following the announcement that it received zero observations during a current Good Manufacturing Practice (cGMP) inspection conducted by the US Food and Drug Administration
The Johnson & Johnson's (J&J) CAPLYTA (lumateperone) product has been given a green light by the U.S. Food and Drug Administration (USFDA) to be used as adjunctive therapy with antidepressants for adult major depressive disorder
The transition from volume-led growth to value- and innovation-led expansion is currently the defining trend of the Indian pharmaceutical business
.jpg)
, CDSCO.jpg)